Roland Walter, MD, PhD, MS Fred Hutchinson Cancer Center

Binaytara Foundation

Legends Of Respiratory Care – Virtual Museum

Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm

About the Editors

Project Finder Leukemia and Lymphoma Society

Roland B. Walter, MD, PhD, MS Fred Hutchinson Cancer Center

Use of Gemtuzumab Ozogamicin for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) or Acute Promyelocytic Leukemia (APL) in an Expanded Access Setting at Our Cancer Consortium - ScienceDirect

Spring 2023 USF Commencement Program by USF Commencement - Issuu

Roland B. Walter M.D., Ph.D., M.S.

ICAHO20 ASCO Direct™ Highlights - Dr. Roland Walter - Updates in Acute Leukemia

Our Team – Binaytara Foundation

IACC Member Bios

Dr. Roland Walter, MD – Seattle, WA

Roland B. Walter, MD PhD MS (@RolandBWalter) / X